Skip to content

Strategy to Avoid Excessive Oxygen in Major Burn Patients

Strategy to Avoid Excessive Oxygen in Major Burn Patients (SAVE-O2)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04534972
Acronym
SAVE-O2
Enrollment
2000
Registered
2020-09-01
Start date
2021-04-15
Completion date
2025-12-31
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Disease Attributes, Pathologic Processes, Wounds and Injury

Keywords

hypoxia, hyperoxia, burn, critical illness, supplemental oxygen, oxygenation, SpO2, PaO2, FiO2, normoxia, hypoxemia, hyperoxemia, normoxemia

Brief summary

The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.

Detailed description

Oxygen therapy has undisputed importance in the care of critically ill patients to prevent secondary complications related to hypoxemia. Although routine, the practice of excessive over-oxygenation may be harmful. An expert panel was convened and developed the strong consensus to target normoxemia at an oxygen saturation (SpO2) range of 90-96%, an arterial oxygen (PaO2) range of 60-100 mmHg (when applicable), and a fraction of inspired oxygen (FiO2) of 21% for mechanically ventilated patients or room air for nonmechanically ventilated patients. Specific Aim: The purpose of this study is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy. Hypotheses: Clinical efforts to through a multimodal educational intervention will: 1. Improve the proportion of time spent within target normoxemia thresholds (oxygen saturation \[SpO2\] 90-96% and/or arterial oxygen \[PaO2\] 60-100 mmHg \[when applicable\]) 2. Limiting use of excessive supplemental oxygen 3. Reduce exposure to hyperoxemia without a substantive increase in hypoxemic episodes or adverse effects

Interventions

Post-implementation of targeted normoxemia through oxygen titration for individual patients. Intervention for treatment of hypoxemia will follow usual local practice. Interventions for treatment of hyperoxemia (SpO2 \>96% or PaO2 \> 100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxemia range is achieved (including room air \[no supplemental oxygen\] for non-mechanically ventilated patients).

Sponsors

United States Department of Defense
CollaboratorFED
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* Patients with acute thermal burn injury who meet the criteria for entry into the state or national burn data repository * Admission to burn unit within 24 hours of burn injury

Exclusion criteria

* Age \<18 years * Prisoners * Known pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Supplemental Oxygen Free Days (SOFD)up to 28 daysNumber of days alive and not on supplemental oxygen during the index hospitalization (0 days \[worst outcome\] to 28 days \[best outcome\])

Secondary

MeasureTime frameDescription
Incidence of Hypoxemic Event (SpO2<88%)up to 90 daysSpO2 saturation below 88% while in the burn unit
Duration of Hypoxemic Events (SpO2<88%)up to 90 daysSpO2 saturation below 88% while in the burn unit
Incidence of Hyperoxemic Event (SpO2>96%)up to 90 daysSpO2 saturation above 96% while in the burn unit
Duration of Hyperoxemic Event (SpO2>96%)up to 90 daysSpO2 saturation above 96% while in the burn unit
Duration of Time Receiving No Supplemental Oxygenup to 90 daysFiO2 0.21 or room air while in the burn unit
Hospital-Free Days to day 90 (HFD90)up to 90 daysNumber of days alive and outside the hospital (0 days \[worst outcome\] to 90 days \[best outcome\])
In-hospital Mortality to day 90up to 90 daysDichotomous vital status (survived or died) at hospital discharge or day 90, whichever is first
Time to Mortality to day 90up to 90 daysVital status and date of death censored at hospital discharge or day 90, whichever is first
Ventilator Free Days (VFD) to day 28up to 28 daysVentilator Free days = Days off ventilator (0 VFD \[worst outcome\] to 28 VFD \[best outcome\])
Time to Room airup to 90 daysDuration of supplemental oxygen (FiO2 = 0.21 or room air)
Time to Burn Wound Healingup to 90 daysWound closure of \>90% of the original burn or time to grafting (for non-full thickness wounds)
Discharge Dispositionup to 90 daysDefined as home (return to prior level of care) or facility (e.g., acute rehab, skilled nursing facility)
Amount of Supplemental Oxygen Administeredup to 90 daysTotal estimated oxygen volume while in the burn until after hospital arrival
Duration of Time on Normoxemia Protocol Targetup to 90 daysDefined as SpO2 90-96% or receiving no supplemental oxygen (FiO2 0.21 or room air) while in the burn unit
Proportion of Participants Receiving High Levels of Supplemental Oxygenup to 90 daysFiO2\>0.40 or \>4 liters per minute for \>2 hours while in the burn unit \[excludes time in the operating room\]
Duration of Time Receiving High Levels of Supplemental Oxygenup to 90 daysFiO2\>0.40 or \>4 liters per minute while in the burn unit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026